Suppr超能文献

信号肽在胰高血糖素样肽-1 受体合成和加工中的作用。

Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.

机构信息

Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, UK.

出版信息

Br J Pharmacol. 2010 Jan;159(1):237-51. doi: 10.1111/j.1476-5381.2009.00517.x. Epub 2009 Nov 27.

Abstract

BACKGROUND AND PURPOSE

The glucagon-like peptide-1 receptor (GLP-1R) belongs to Family B of the G protein-coupled receptor superfamily and is a target for treatment of type 2 diabetes. Family B G protein-coupled receptors contain a putative N-terminal signal peptide, but its role in receptor synthesis and trafficking are unclear. Further, the signal peptide is not cleaved in at least one family member.

EXPERIMENTAL APPROACH

We examined receptor glycosylation and the role of the signal peptide in GLP-1R synthesis and trafficking using constructs containing epitope tags at the N- and/or C-terminus and in which the signal peptide sequence was either present or absent.

KEY RESULTS

The signal peptide was absolutely required for GLP-1R synthesis but could be substituted to some extent by increasing positive charge in the N-terminal region of the receptor flanking the signal peptide. The signal peptide is cleaved during synthesis and processing of the receptor. An enhanced GFP-epitope tag at the N-terminus of the receptor permitted synthesis of the receptor but blocked signal peptide cleavage and prevented trafficking to the plasma membrane. Cleavage site mutation allowed synthesis of a full-length receptor, blocked signal peptide cleavage and caused retention within the endoplasmic reticulum.

CONCLUSIONS AND IMPLICATIONS

Signal peptide cleavage was not essential for receptor synthesis but was obligatory for processing and trafficking of receptors to the plasma membrane. Further, the GLP-1R is subject to N-linked glycosylation and only the mature, fully glycosylated form of the receptor is present in the plasma membrane. Inhibition of glycosylation prevents processing and cell surface expression of the GLP-1R.

摘要

背景与目的

胰高血糖素样肽-1 受体(GLP-1R)属于 G 蛋白偶联受体超家族的 B 族,是治疗 2 型糖尿病的靶点。B 族 G 蛋白偶联受体包含一个假定的 N 端信号肽,但它在受体合成和转运中的作用尚不清楚。此外,至少有一种家族成员的信号肽不被切割。

实验方法

我们使用在 N 端和/或 C 端含有表位标签的构建体,研究了信号肽在 GLP-1R 合成和转运中的作用,其中信号肽序列要么存在,要么不存在。

主要结果

信号肽绝对是 GLP-1R 合成所必需的,但通过增加信号肽侧翼的受体 N 端的正电荷,可以在一定程度上替代信号肽。信号肽在受体的合成和加工过程中被切割。受体 N 端的 GFP-表位标签增强了受体的合成,但阻断了信号肽的切割,阻止了其向质膜的转运。切割位点突变允许全长受体的合成,阻断了信号肽的切割,并导致其在内质网中滞留。

结论和意义

信号肽切割对受体合成不是必需的,但对受体的加工和向质膜的转运是必需的。此外,GLP-1R 受到 N-连接糖基化的影响,只有成熟的、完全糖基化的受体形式存在于质膜中。糖基化的抑制阻止了 GLP-1R 的加工和细胞表面表达。

相似文献

1
Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.
Br J Pharmacol. 2010 Jan;159(1):237-51. doi: 10.1111/j.1476-5381.2009.00517.x. Epub 2009 Nov 27.
4
Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
J Biol Chem. 2015 Jan 9;290(2):1233-43. doi: 10.1074/jbc.M114.592436. Epub 2014 Dec 1.
5
Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor.
Mol Endocrinol. 2006 Dec;20(12):3400-11. doi: 10.1210/me.2006-0178. Epub 2006 Aug 24.
7
Distinct regions in the C-Terminus required for GLP-1R cell surface expression, activity and internalisation.
Mol Cell Endocrinol. 2015 Sep 15;413:66-77. doi: 10.1016/j.mce.2015.06.012. Epub 2015 Jun 24.
9
A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
J Biol Chem. 2001 Oct 12;276(41):37787-93. doi: 10.1074/jbc.M106692200. Epub 2001 Aug 9.
10
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
J Biol Chem. 2008 Apr 25;283(17):11340-7. doi: 10.1074/jbc.M708740200. Epub 2008 Feb 20.

引用本文的文献

1
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2025;24(3):196-207. doi: 10.2174/0118715273321002240919102841.
2
Rapid One-Step Capturing of Native, Cell-Free Synthesized and Membrane-Embedded GLP-1R.
Int J Mol Sci. 2023 Feb 1;24(3):2808. doi: 10.3390/ijms24032808.
4
Reagents and models for detecting endogenous GLP1R and GIPR.
EBioMedicine. 2021 Dec;74:103739. doi: 10.1016/j.ebiom.2021.103739. Epub 2021 Dec 12.
5
The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor.
Front Pharmacol. 2020 Aug 13;11:1271. doi: 10.3389/fphar.2020.01271. eCollection 2020.
6
The PAR2 signal peptide prevents premature receptor cleavage and activation.
PLoS One. 2020 Feb 20;15(2):e0222685. doi: 10.1371/journal.pone.0222685. eCollection 2020.
7
Glucagon-like peptide 1 (GLP-1).
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
8
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.
PLoS Biol. 2019 Aug 20;17(8):e3000097. doi: 10.1371/journal.pbio.3000097. eCollection 2019 Aug.
9
Liraglutide modulates adipokine expression during adipogenesis, ameliorating obesity, and polycystic ovary syndrome in mice.
Endocrine. 2019 May;64(2):349-366. doi: 10.1007/s12020-019-01891-3. Epub 2019 Mar 23.
10
Prediction of Signal Peptides in Proteins from Malaria Parasites.
Int J Mol Sci. 2018 Nov 22;19(12):3709. doi: 10.3390/ijms19123709.

本文引用的文献

2
PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.
J Biol Chem. 2008 Dec 19;283(51):35474-85. doi: 10.1074/jbc.M800951200. Epub 2008 Oct 28.
3
Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists.
J Mol Model. 2009 Jan;15(1):53-65. doi: 10.1007/s00894-008-0372-2. Epub 2008 Oct 22.
4
Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors.
Mol Endocrinol. 2008 Jun;22(6):1489-99. doi: 10.1210/me.2008-0025. Epub 2008 Mar 27.
5
Guide to Receptors and Channels (GRAC), 3rd edition.
Br J Pharmacol. 2008 Mar;153 Suppl 2(Suppl 2):S1-209. doi: 10.1038/sj.bjp.0707746.
6
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
J Biol Chem. 2008 Apr 25;283(17):11340-7. doi: 10.1074/jbc.M708740200. Epub 2008 Feb 20.
7
Biology of incretins: GLP-1 and GIP.
Gastroenterology. 2007 May;132(6):2131-57. doi: 10.1053/j.gastro.2007.03.054.
8
A molecular basis of analgesic tolerance to cannabinoids.
J Neurosci. 2007 Apr 11;27(15):4165-77. doi: 10.1523/JNEUROSCI.5648-06.2007.
9
Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Pharmacol Ther. 2007 Mar;113(3):546-93. doi: 10.1016/j.pharmthera.2006.11.007. Epub 2006 Dec 28.
10
The corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide.
J Biol Chem. 2006 Aug 25;281(34):24910-21. doi: 10.1074/jbc.M601554200. Epub 2006 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验